EICHORCondition: Acute Kidney Injury · Intensive Care · Renal Replacement Therapy · Sponsor: Huede Healthtech Co., Ltd.
Interested? Contact the study team ↓
"Huede" AI Aided AKI Prediction Software, Acura AKI, uses machine learning algorithms to predict the risk of AKI within the next 24 hours and provide a ranking of feature importance. By using Acura AKI, physicians can assess the risk of AKI, focusing on high-risk patients to provide care decisions. This study will be conducted in a prospective randomized clinical trial in adult ICUs, implementing the Acura AKI system for predicting AKI. The study aims to determine whether early prediction and intervention using the Acura AKI system can improve the outcomes of critically ill patients with adverse kidney conditions. The study endpoint is to evaluate the cost-effectiveness of using Acura AKI, including the incidence of AKI, dialysis rates, mortality rates, length of hospital stay, and treatment costs.
This description comes directly from the study's public registry record.
Chun-Te Huang · +8864-23592525 · huangchunte@gmail.com
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Over 20 years old * Admitted to adult ICU * Hospital stay of more than 30 hours Exclusion Criteria: * Known to have acute kidney injury at enrollment * Currently undergoing hemodialysis treatment * No available blood or urine test data * Pregnant women * HIV-positive patients * Those who have not provided informed consent form * Regarded as unsuitable for inclusion in the trial by the researcher
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Taichung Veterans General Hospital (TCVGH) | Taichung, Taiwan | Recruiting |
This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06685367